Melissa A. Geller

Gene expression markers of Tumor Infiltrating Leukocytes

Patrick Danaher, Sarah Warren, Lucas Dennis et al. · Journal for ImmunoTherapy of Cancer · 2017 · 824 citations · Full text

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller et al. · The Lancet Oncology · 2019 · 516 citations

Oncology, Metronomic Therapy, Gynecology +6

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

Melissa A. Geller, Sarah Cooley, Patricia L. Judson et al. · Cytotherapy · 2010 · 426 citations · Full text

Breast Oncology, Medicine, Immunology +10

Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy

Pamela C. Rosato, Sathi Wijeyesinghe, J. Michael Stolley et al. · Nature Communications · 2019 · 289 citations · Full text

Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum

Melissa S. DeRycke, Stefan E. Pambuccian, C. Blake Gilks et al. · American Journal of Clinical Pathology · 2010 · 257 citations · Full text

Tumor Biology, Oncology, Nectin 4 +13